Exposure of the murine RAW 264.7 macrophage cell line to hydroxyapatite dispersions of various composition and morphology: Assessment of cytotoxicity, activation and stress response

Toxicology in Vitro

Volumn 23, Issue 3, 2009, Pages 531-538

  Scheel, Julia ^b   Weimans, Sabine ^a   Thiemann, Astrid ^a   Heisler, Eckhard ^a   Hermann, Martina ^b  

^a Evonik Stockhausen GmbH   (Germany)

^b HENKEL KGAA   (Germany)

Author keywords

Biocompatibility; Cytotoxicity; Hydroxyapatite; Inflammation; Macrophages; Nanomaterials; Nitric oxide; Oxidative stress

Indexed keywords

HYDROXYAPATITE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL COMPOSITION; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; MACROPHAGE; MOUSE; NONHUMAN;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOKINES; HYDROXYAPATITES; LIPOPOLYSACCHARIDES; MACROPHAGES; MATERIALS TESTING; MICE; NANOPARTICLES; NITRIC OXIDE; OXIDATIVE STRESS; PARTICLE SIZE; QUARTZ;

MURINAE;

EID: 60549103852     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.01.007     Document Type: Article

References (46)

1. Aktan F. INOS-mediated nitric oxide production and its regulation. Life Sciences 75 (2004) 639-653
2. Albrecht C., Schins R.P., Hohr D., Becker A., Shi T., Knaapen A.M., and Borm P.J. Inflammatory time course after quartz instillation: role of tumor necrosis factor-alpha and particle surface. American Journal of Respiratory Cell and Molecular Biology 31 (2004) 292-301
3. Albrecht C., Hohr D., Haberzettl P., Becker A., Borm P.J., and Schins R.P. Surface-dependent quartz uptake by macrophages: potential role in pulmonary inflammation and lung clearance. Inhalation Toxicology 19 Suppl. 1 (2007) 39-48
4. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. The Biochemical Journal 357 (2001) 593-615
5. Arts C.J.J., Verdonschot N., Schreurs B.W., and Buma P. The use of a bioresorbable nano-crystalline hydroxyapatite paste in acetabular bone impaction grafting. Biomaterials 27 (2006) 1110-1118
6. Bauss F., Droge W., and Mannel D.N. Tumor necrosis factor mediates endotoxic effects in mice. Infection and Immunity 55 (1987) 1622-1625
7. Bloebaum R.D., Lundeen G.A., Bachus K.N., Ison I., and Hofmann A.A. Dissolution of particulate hydroxyapatite in a macrophage organelle model. Journal of Biomedical Materials Research 40 (1998) 104-114
8. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., and Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and Fibre Toxicology 3 (2006) 11
9. Brunauer S., Emmett P.H., and Teller E. Adsorption of gases in multimolecular layers. Journal of the American Chemical Society 60 (1938) 309-319
10. Chapekar M.S., Zaremba T.G., Kuester R.K., and Hitchins V.M. Synergistic induction of tumor necrosis factor alpha by bacterial lipopolysaccharide and lipoteichoic acid in combination with polytetrafluoroethylene particles in a murine macrophage cell line RAW 264.7. Journal of Biomedical Materials Research 31 (1996) 251-256
11. Cui F.Z., CDU C., Su X.W., Zhu X.D., and Zhao N.M. Biodegradation of a nano-hydroxyapatite/collagen composite by peritoneal monocyte macrophages. Cells and Materials 6 (1996) 31-44
12. Dinarello C.A. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. Journal of Biological Regulators and Homeostatic Agents 11 (1997) 91-103
13. Diociaiuti M., Balduzzi M., De Berardis B., Cattani G., Stacchini G., Ziemacki G., Marconi A., and Paoletti L. The two PM(2.5) (fine) and PM(2.5-10) (coarse) fractions: evidence of different biological activity. Environmental Research 86 (2001) 254-262
14. Dorger M., and Krombach F. Interaction of alveolar macrophages with inhaled mineral particulates. Journal of Aerosol Medicine 13 (2000) 369-380
15. Duffin R., Tran L., Brown D., Stone V., and Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhalation Toxicology 19 (2007) 849-856
16. Evans E.J. Toxicity of hydroxyapatite in vitro: the effect of particle size. Biomaterials 12 (1991) 574-576
17. Forman H.J., and Torres M. Redox signaling in macrophages. Molecular Aspects of Medicine 22 (2001) 189-216
18. Forstermann U., and Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Archives of Pharmacology 352 (1995) 351-364
19. Fubini B. Surface chemistry and quartz hazard. The Annals of Occupational Hygiene 42 (1998) 521-530
20. Fubini B., and Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free radical Biology and Medicine 34 (2003) 1507-1516
21. Fujiwara N., and Kobayashi K. Macrophages in inflammation. Current Drug Targets 4 (2005) 281-286
22. Grandjean-Laquerriere A., Laquerriere P., Laurent-Maquin D., Guenounou M., and Phillips T.M. The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro. Biomaterials 25 (2004) 5921-5927
23. Grandjean-Laquerriere A., Laquerriere P., Guenounou M., Laurent-Maquin D., and Phillips T.M. Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 26 (2005) 2361-2369
24. Guo X., Zheng Q., Du J., Zen H., Quan D., Yan Y., Li S., and Li X. Biocompatibility of self-designed absorbable hydroxyapatite/poly (dl-lactide) composites. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 16 (1999) 135-139
25. Guo X., Gough J.E., Xiao P., Liu J., and Shen Z. Fabrication of nanostructured hydroxyapatite and analysis of human osteoblastic cellular response. Journal of Biomedical Materials Research A 82 (2007) 1022-1032
26. Heraeus, Kulzer, 2005. Ostim, Product Information, Scientific Information. .
27. Hirvonen M.R., Brune B., and Lapetina E.G. Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. The Biochemical Journal 315 Pt 3 (1996) 845-849
28. Huang J., Best S.M., Bonfield W., Brooks R.A., Rushton N., Jayasinghe S.N., and Edirisinghe M.J. In vitro assessment of the biological response to nano-sized hydroxyapatite. Journal of Materials Science. Materials in Medicine 15 (2004) 441-445
29. Huber F.X., Belyaev O., Hillmeier J., Kock H.J., Huber C., Meeder P.J., and Berger I. First histological observations on the incorporation of a novel nanocrystalline hydroxyapatite paste OSTIM in human cancellous bone. BMC Musculoskeletal Disorders 7 (2006) 50
30. Huber, F.X., Berger, I., McArthur, N., Huber, C., Kock, H.P., Hillmeier, J., Meeder, P.J., 2007. Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treatment of critical size bone defects (CSD) in rabbits. Journal of Materials Science: Materials in Medicine.
31. Kagan V.E., Tyurina Y.Y., Tyurin V.A., Konduru N.V., Potapovich A.I., Osipov A.N., Kisin E.R., Schwegler-Berry D., Mercer R., Castranova V., and Shvedova A.A. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicology Letters 165 (2006) 88-100
32. Kaiser R., and Gottschalk G. Elementare Tests zur Beurteilung von Meßdaten (1972), Bibliographisches Institut, Mannheim
33. Korhonen R., Lahti A., Kankaanranta H., and Moilanen E. Nitric oxide production and signaling in inflammation. Current Drug Targets 4 (2005) 471-479
34. Laquerriere P., Grandjean-Laquerriere A., Jallot E., Balossier G., Frayssinet P., and Guenounou M. Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro. Biomaterials 24 (2003) 2739-2747
35. Liu C., Wang W., Shen W., Chen T., Hu L., and Chen Z. Evaluation of the biocompatibility of a nonceramic hydroxyapatite. Journal of Endodontics 23 (1997) 490-493
36. Mariotto S., Menegazzi M., and Suzuki H. Biochemical aspects of nitric oxide. Current Pharmaceutical Design 10 (2004) 1627-1645
37. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87 (2007) 315-424
38. Ramesh M., Turner L.F., Yadav R., Rajan T.V., Vella A.T., and Kuhn L.T. Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response. International Immunopharmacology 7 (2007) 1617-1629
39. Raschke W., Baird S., Ralph P., and Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15 (1976) 261-267
40. Rumpel E., Wolf E., Kauschke E., Bienengraber V., Bayerlein T., Gedrange T., and Proff P. The biodegradation of hydroxyapatite bone graft substitutes in vivo. Folia Morphologiica (Warsz) 65 (2006) 43-48
41. 2: role of the specific surface area and of surface methylation of the particles. Toxicology and Applied Pharmacology 222 (2007) 141-151
42. Tracey K.J., Lowry S.F., and Cerami A. Cachectin/TNF mediates the pathophysiological effects of bacterial endotoxin/lipopolysaccharide (LPS). Progress in Clinical and Biological Research 272 (1988) 77-88
43. Trofimov V.V., Klimenov V.A., Kazimirovskaia V.B., and Mansurova L.A. A biological compatibility study of hydroxyapatite. Stomatologiia (Mosk) 75 (1996) 20-22
44. Verdon C.P., Burton B.A., and Prior R.L. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Analytical Biochemistry 224 (1995) 502-508
45. Wenisch S., Stahl J.P., Horas U., Heiss C., Kilian O., Trinkaus K., Hild A., and Schnettler R. In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: fine structural microscopy. Journal of Biomedical Materials Research A 67 (2003) 713-718
46. Zhang X., and Mosser D. Macrophage activation by endogenous danger signals. The Journal of Pathology 214 (2008) 161-178